Advantage Alpha Capital Partners LP Haemonetics Corp Transaction History

Advantage Alpha Capital Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $4.06 Million - $5.1 Million	-36,536 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $4.86 Million - $6.56 Million	-54,710 Reduced 59.96%	36,536 $4.34 Million
Q3 2020 Nov 16, 2020	SELL	$75.65 - $93.58 $675,100 - $835,107	-8,924 Reduced 8.91%	91,246 $7.96 Million
Q2 2020 Aug 13, 2020	BUY	$84.96 - $118.91 $6.32 Million - $8.84 Million	74,352 Added 287.99%	100,170 $8.97 Million
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $1.92 Million - $3.15 Million	25,818 New	25,818 $2.57 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.58B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.